Open Access. Powered by Scholars. Published by Universities.®
Digestive, Oral, and Skin Physiology Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Keyword
-
- Adult (1)
- Bariatric Surgery (1)
- Chi-Square Distribution (1)
- Cholecalciferol (1)
- Cohort Studies (1)
-
- Dietary Proteins (1)
- Exercise Test (1)
- Female (1)
- Hand Strength (1)
- Humans (1)
- Lactobacillus (1)
- Male (1)
- Middle Aged (1)
- Nonparametric (1)
- PKU (1)
- Pharmabiotic (1)
- Phenylalanine (1)
- Phenylalanine hydroxylase (1)
- Phenylketonuria (1)
- Retrospective Studies (1)
- Statistics (1)
- Statistics, Nonparametric (1)
- Walk Test (1)
- Publication Type
Articles 1 - 2 of 2
Full-Text Articles in Digestive, Oral, and Skin Physiology
Assessment Of Physical Fitness After Bariatric Surgery And Its Association With Protein Intake And Type Of Cholecalciferol Supplementation, Hendrika J M Smelt, Sjaak Pouwels, Alper Celik, Adarsh Gupta, Johannes F Smulders
Assessment Of Physical Fitness After Bariatric Surgery And Its Association With Protein Intake And Type Of Cholecalciferol Supplementation, Hendrika J M Smelt, Sjaak Pouwels, Alper Celik, Adarsh Gupta, Johannes F Smulders
Rowan-Virtua School of Osteopathic Medicine Faculty Scholarship
Background: Several studies showed that there is a relationship between vitamin and mineral status and muscle strength. In particular this is the case for handgrip strength (HS) and vitamin D deficiency. In bariatric surgery there is a risk of decrease in muscle strength after surgery and also vitamin and mineral deficiencies are not uncommon. The aim of this study is to assess the effect of low vitamin 25 (OH) cholecalciferol levels, high dose cholecalciferol supplementation regime and protein intake on physical fitness, measured using handgrip strength (HS) and the shuttle walk run test (SWRT). Methods: For this retrospective …
The Pharmabiotic For Phenylketonuria: Development Of A Novel Therapeutic, Chloé Elizabeth Lebegue
The Pharmabiotic For Phenylketonuria: Development Of A Novel Therapeutic, Chloé Elizabeth Lebegue
Senior Theses
Phenylketonuria, now known as phenylalanine hydroxylase (PAH) deficiency, is a genetic disorder of metabolism affecting approximately one in every 15,000 infants born in the United States. Patients have nonfunctional PAH enzyme secondary to one or more genetic mutations. The enzyme deficit results in destructive supraphysiologic blood phenylalanine levels upon consumption of the essential dietary amino acid phenylalanine. Current standards of care mitigate signs and symptoms of the disorder, but do not approach a cure. The methods for creating a prototype pharmabiotic as an innovative treatment strategy for PAH deficiency are described herein.
DNA molecular cloning techniques were utilized to engineer …